4cn binaka adb 4-CN-BINACA-ADB CAS NO :17764 18 0 Powder Pharmaceutical Raw Materials

  • 4cn binaka adb 4-CN-BINACA-ADB CAS NO :17764 18 0 Powder Pharmaceutical Raw Materials
  • 4cn binaka adb 4-CN-BINACA-ADB CAS NO :17764 18 0 Powder Pharmaceutical Raw Materials
  • China
  • ISO,CE
  • 1 Grams
  • USD $1 - $10 / Gram
  • D/A,Western Union
Send Message
More Product Details

Product Details:

We are professional supplier for research chemicals in China,Dibutylone ,Etizolam,2FDCK,5FADB, 
ADB-F,4F-PHP,U-48800,BK-EPDP,Hexen, AB-FUBINACA,4-FEA,4-CMC,Methoxyacetyl,fentanyl (MAF),2NMC,4CEC,4CPRC,4MPD,medhylone,furanylfentanyl,Thpvp, 
mexedrone,U-49900,MMB2101,MMB-Chminaca ,FlubroMazolaM,etc

Our service:

1,High putiry good quality with pretty competitive price

2,Safety and fast shipment by sea/by air/by express

3,Delivery time will be within 12 hours

4,Convenient pay meny terms by TT/Western union /Moneygram/Bitcoin,etc

4-cyano CUMYL-BUTINACA (1631074-54-8) | Cayman

CUMYL-4CN-BINACA is an efficacious and potent pro-convulsant synthetic cannabinoid receptor agonist. Front. Pharmacol. 10, 595 (2019). Technical Support 

CUMYL-4CN-BINACA - World Health Organization

Nov 12, 2018 - Motor vehicle collisions caused by the 'super-strength' synthetic cannabinoids,. MAM-2201, 5F-PB-22, 5F-AB-PINACA, 5F-AMB and 5F-ADB in 

CUMYL-4CN-BINACA Is an Efficacious and Potent ... - Frontiers

May 29, 2019 - CUMYL-4CN-BINACA (1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)indazole-3-carboxamide) is structurally related to potent, cumylamine-derived 

CUMYL-4CN-BINACA Is an Efficacious and Potent Pro ... - NCBI

May 29, 2019 - We report here that CUMYL-4CN-BINACA is a potent CB1 receptor agonist (K i = 2.6 nM; EC50 = 0.58 nM) that produces pro-convulsant effects 

CUMYL-4CN-BINACA - Wikipedia

CUMYL-4CN-BINACA is an indazole-3-carboxamide based synthetic cannabinoid that has been sold online as a designer drug. It is a potent agonist for 

Writing a Message
  • Please Enter your Subject.
  • Please enter Your valid email address.
Your inquiry content must be between 20 to 5000 characters..